Thomson Reuters

"I need to secure early, exclusive sources of API supply."

Overview

With new markets opening throughout the developing world...

...an aging population in established markets, governments and employers striving to reign in healthcare expenditure, and so many blockbuster drugs edging toward patent expiry, the generic industry offers phenomenal opportunities.

However, generic dose prices are falling in many countries, squeezing margins. The number of players is increasing, while low-cost active ingredients from India and China further depress prices.  

So how do you keep ahead of your competitors? How do you chase down the drugs to target, source APIs, and identify licensing and acquisitioning opportunities?

We track, monitor and expertly analyze ongoing developments in thousands of launched products and companies operating in the global pharmaceutical market.

By incorporating the unique strategic intelligence and powerful competitive analysis that is only available from Thomson Reuters, we could ensure you’ll be first to find the drug, first to find the niche, first to make the deal, and first to get to market.

If you’re an innovator, we can give you up to seven years’ advance warning of patent challenges and attempts at circumvention. Our powerful competitive intelligence and analytical tools can help you identify, assess and track the earliest signs of generic competition.

Generic Offerings

For Generics & API Manufacturers

• Newport Horizon Premium:The critical product targeting, global business development and APIsourcing system from Thomson, the industry authority on the globalgenerics market.
• Newport Horizon Global:The critical product targeting and global business development systemfrom Thomson Reuters, the industry authority on the global genericsmarket.
• Newport Horizon Sourcing: Expert competitive intelligence for generic pharmaceutical companies and strategic API manufacturers.
• If you are an API manufacturer and would like to update information aboutyour product line and manufacturing capabilities, please fill out the API Manufacturers Form.

 

For Innovators

• Newport Vision Premium:The most advanced competitive intelligence, business development andglobal active pharmaceutical ingredient sourcing system from ThomsonReuters, the industry authority on the global generics market.
• Newport Vision CI:The critical competitive intelligence and global business developmentsystem from Thomson Reuters, the industry authority on the globalgenerics market.
• Newport Vision Sourcing: Expert sourcing and competitive intelligence system for innovator, niche brand, and specialty pharmaceutical companies.
  

Key Events

Join Thomson Reuters at the 11th Annual IGPA Conference on December 8 - 10 in Geneva, Switzerland. 

Keynote speakers include Pascal Lamy, Director General, WTO and Francis Gurry, Director General, WIPO.

Generic Medicines: A global market, a global industry.

Additional Resources

Our overview of the most significant game-play in the US generics market.

 

 

 

Stay ahead of the latest trends and find out who’s doing what - with the Pharma Knowledge Hub.

Industry Information: Download glossary of industry termsPDF

System Support